APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Anxiety Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-Anxiety Drugs Industry Growth and Trends Forecast to 2032

31 December 202595 pages

Choose your research edition.

Industry ResearchAnti-Anxiety Drugs Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Anxiety Drugs Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Anti-Anxiety Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Anxiety Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Anxiety Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Anti-Anxiety Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-Anxiety Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-Anxiety Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Anxiety Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-Anxiety Drugs include JIANFENG Pharmaceutical, HUAHAI PHARMACEUTICAL, Mylan, Gsk, KANGHONG PHARMACEUTICAL, Win Sunny, Zydus Pharmaceutical, Eli Lilly And Company and APOTEX, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-Anxiety Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-Anxiety Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-Anxiety Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-Anxiety Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-Anxiety Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-Anxiety Drugs Market by Company

JIANFENG Pharmaceutical

HUAHAI PHARMACEUTICAL

Mylan

Gsk

KANGHONG PHARMACEUTICAL

Win Sunny

Zydus Pharmaceutical

Eli Lilly And Company

APOTEX

Anti-Anxiety Drugs Segment by Type

Patent Medicine

Generic Drugs

Others

Anti-Anxiety Drugs Segment by Application

Help Sleep

Treat anxiety

Treat Premature Ejaculation

Others

Anti-Anxiety Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Anxiety Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Anxiety Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Anxiety Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-Anxiety Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-Anxiety Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Patent Medicine Table 2. Major Company of Generic Drugs Table 3. Major Company of Others Table 4. Global Anti-Anxiety Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Anti-Anxiety Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Anti-Anxiety Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Anti-Anxiety Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Anti-Anxiety Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Anti-Anxiety Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Anti-Anxiety Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Anti-Anxiety Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Anti-Anxiety Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Anti-Anxiety Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Anti-Anxiety Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Anti-Anxiety Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Anti-Anxiety Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Anti-Anxiety Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Anti-Anxiety Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Anti-Anxiety Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Anti-Anxiety Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Anti-Anxiety Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Anti-Anxiety Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Anti-Anxiety Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Anti-Anxiety Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Anti-Anxiety Drugs Industry Trends Table 26. Anti-Anxiety Drugs Industry Drivers Table 27. Anti-Anxiety Drugs Industry Opportunities and Challenges Table 28. Anti-Anxiety Drugs Industry Restraints Table 29. Global Anti-Anxiety Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Anti-Anxiety Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Anti-Anxiety Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Anti-Anxiety Drugs Sales Share by Company (2021-2026) Table 33. Global Anti-Anxiety Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Anti-Anxiety Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Anti-Anxiety Drugs Major Company Production Sites and Headquarters Table 36. Global Anti-Anxiety Drugs Company, Product Type & Application Table 37. Global Anti-Anxiety Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Anti-Anxiety Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Anti-Anxiety Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Anti-Anxiety Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Anti-Anxiety Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Anti-Anxiety Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Anti-Anxiety Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Anti-Anxiety Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Anti-Anxiety Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Anti-Anxiety Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Anti-Anxiety Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Anti-Anxiety Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Anti-Anxiety Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Anti-Anxiety Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Anti-Anxiety Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Anti-Anxiety Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Anti-Anxiety Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Anti-Anxiety Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Anti-Anxiety Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Anti-Anxiety Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Anti-Anxiety Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Anti-Anxiety Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Anti-Anxiety Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Anti-Anxiety Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Anti-Anxiety Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Anti-Anxiety Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Anti-Anxiety Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Anti-Anxiety Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Anti-Anxiety Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Anti-Anxiety Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Anti-Anxiety Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Anti-Anxiety Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Anti-Anxiety Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Anti-Anxiety Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. JIANFENG Pharmaceutical Company Information Table 73. JIANFENG Pharmaceutical Business Overview Table 74. JIANFENG Pharmaceutical Anti-Anxiety Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. JIANFENG Pharmaceutical Anti-Anxiety Drugs Product Portfolio Table 76. JIANFENG Pharmaceutical Recent Development Table 77. HUAHAI PHARMACEUTICAL Company Information Table 78. HUAHAI PHARMACEUTICAL Business Overview Table 79. HUAHAI PHARMACEUTICAL Anti-Anxiety Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. HUAHAI PHARMACEUTICAL Anti-Anxiety Drugs Product Portfolio Table 81. HUAHAI PHARMACEUTICAL Recent Development Table 82. Mylan Company Information Table 83. Mylan Business Overview Table 84. Mylan Anti-Anxiety Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Mylan Anti-Anxiety Drugs Product Portfolio Table 86. Mylan Recent Development Table 87. Gsk Company Information Table 88. Gsk Business Overview Table 89. Gsk Anti-Anxiety Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Gsk Anti-Anxiety Drugs Product Portfolio Table 91. Gsk Recent Development Table 92. KANGHONG PHARMACEUTICAL Company Information Table 93. KANGHONG PHARMACEUTICAL Business Overview Table 94. KANGHONG PHARMACEUTICAL Anti-Anxiety Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. KANGHONG PHARMACEUTICAL Anti-Anxiety Drugs Product Portfolio Table 96. KANGHONG PHARMACEUTICAL Recent Development Table 97. Win Sunny Company Information Table 98. Win Sunny Business Overview Table 99. Win Sunny Anti-Anxiety Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Win Sunny Anti-Anxiety Drugs Product Portfolio Table 101. Win Sunny Recent Development Table 102. Zydus Pharmaceutical Company Information Table 103. Zydus Pharmaceutical Business Overview Table 104. Zydus Pharmaceutical Anti-Anxiety Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Zydus Pharmaceutical Anti-Anxiety Drugs Product Portfolio Table 106. Zydus Pharmaceutical Recent Development Table 107. Eli Lilly And Company Company Information Table 108. Eli Lilly And Company Business Overview Table 109. Eli Lilly And Company Anti-Anxiety Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Eli Lilly And Company Anti-Anxiety Drugs Product Portfolio Table 111. Eli Lilly And Company Recent Development Table 112. APOTEX Company Information Table 113. APOTEX Business Overview Table 114. APOTEX Anti-Anxiety Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. APOTEX Anti-Anxiety Drugs Product Portfolio Table 116. APOTEX Recent Development Table 117. North America Anti-Anxiety Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. North America Anti-Anxiety Drugs Sales by Country (2021-2026) & (K Units) Table 119. North America Anti-Anxiety Drugs Sales Market Share by Country (2021-2026) Table 120. North America Anti-Anxiety Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 121. North America Anti-Anxiety Drugs Sales Market Share Forecast by Country (2027-2032) Table 122. North America Anti-Anxiety Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Anti-Anxiety Drugs Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Anti-Anxiety Drugs Market Share by Country (2021-2026) Table 125. North America Anti-Anxiety Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Anti-Anxiety Drugs Market Share Forecast by Country (2027-2032) Table 127. Europe Anti-Anxiety Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Europe Anti-Anxiety Drugs Sales by Country (2021-2026) & (K Units) Table 129. Europe Anti-Anxiety Drugs Sales Market Share by Country (2021-2026) Table 130. Europe Anti-Anxiety Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 131. Europe Anti-Anxiety Drugs Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Anti-Anxiety Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Anti-Anxiety Drugs Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Anti-Anxiety Drugs Market Share by Country (2021-2026) Table 135. Europe Anti-Anxiety Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Anti-Anxiety Drugs Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Anti-Anxiety Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Anti-Anxiety Drugs Sales by Country (2021-2026) & (K Units) Table 139. Asia-Pacific Anti-Anxiety Drugs Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Anti-Anxiety Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 141. Asia-Pacific Anti-Anxiety Drugs Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Anti-Anxiety Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Anti-Anxiety Drugs Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Anti-Anxiety Drugs Market Share by Country (2021-2026) Table 145. Asia-Pacific Anti-Anxiety Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Anti-Anxiety Drugs Market Share Forecast by Country (2027-2032) Table 147. Latin America Anti-Anxiety Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Latin America Anti-Anxiety Drugs Sales by Country (2021-2026) & (K Units) Table 149. Latin America Anti-Anxiety Drugs Sales Market Share by Country (2021-2026) Table 150. Latin America Anti-Anxiety Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 151. Latin America Anti-Anxiety Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Anti-Anxiety Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Anti-Anxiety Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Anti-Anxiety Drugs Market Share by Country (2021-2026) Table 155. Latin America Anti-Anxiety Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Anti-Anxiety Drugs Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Anti-Anxiety Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Anti-Anxiety Drugs Sales by Country (2021-2026) & (K Units) Table 159. Middle East and Africa Anti-Anxiety Drugs Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Anti-Anxiety Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 161. Middle East and Africa Anti-Anxiety Drugs Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Anti-Anxiety Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Anti-Anxiety Drugs Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Anti-Anxiety Drugs Market Share by Country (2021-2026) Table 165. Middle East and Africa Anti-Anxiety Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Anti-Anxiety Drugs Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Anti-Anxiety Drugs Distributors List Table 170. Anti-Anxiety Drugs Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Anti-Anxiety Drugs Image Figure 2. Global Anti-Anxiety Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Anxiety Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Anxiety Drugs Sales (2021-2032) & (K Units) Figure 5. Patent Medicine Image Figure 6. Global Patent Medicine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Generic Drugs Image Figure 8. Global Generic Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Anti-Anxiety Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Anti-Anxiety Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Anti-Anxiety Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Anti-Anxiety Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Anti-Anxiety Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Anti-Anxiety Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Anti-Anxiety Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Anti-Anxiety Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Anti-Anxiety Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Anti-Anxiety Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Anti-Anxiety Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Anti-Anxiety Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Anti-Anxiety Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Help Sleep Image Figure 26. Global Help Sleep Sales YoY Growth (2021-2032) & (K Units) Figure 27. Treat anxiety Image Figure 28. Global Treat anxiety Sales YoY Growth (2021-2032) & (K Units) Figure 29. Treat Premature Ejaculation Image Figure 30. Global Treat Premature Ejaculation Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Anti-Anxiety Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Anti-Anxiety Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Anti-Anxiety Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Anti-Anxiety Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Anti-Anxiety Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Anti-Anxiety Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Anti-Anxiety Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Anti-Anxiety Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Anti-Anxiety Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Anti-Anxiety Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Anti-Anxiety Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Anti-Anxiety Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Anti-Anxiety Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Anti-Anxiety Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Anti-Anxiety Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Anti-Anxiety Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Anti-Anxiety Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Anti-Anxiety Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Anti-Anxiety Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Anti-Anxiety Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Anti-Anxiety Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Anti-Anxiety Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Anti-Anxiety Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Anti-Anxiety Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Anti-Anxiety Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Anti-Anxiety Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Anti-Anxiety Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Anti-Anxiety Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Anti-Anxiety Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Anti-Anxiety Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Anti-Anxiety Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Anti-Anxiety Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Anti-Anxiety Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Anti-Anxiety Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Patent Medicine
  • Generic Drugs
  • Others
Applications
  • Help Sleep
  • Treat anxiety
  • Treat Premature Ejaculation
  • Others
Companies covered
  • JIANFENG Pharmaceutical
  • HUAHAI PHARMACEUTICAL
  • Mylan
  • Gsk
  • KANGHONG PHARMACEUTICAL
  • Win Sunny
  • Zydus Pharmaceutical
  • Eli Lilly And Company
  • APOTEX

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-Anxiety Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-Anxiety Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-Anxiety Drugs Market by Type
  6. 1.3.1 Patent Medicine
  7. 1.3.2 Generic Drugs
  8. 1.3.3 Others
  9. 1.4 Global Anti-Anxiety Drugs Market Size by Type
  10. 1.4.1 Global Anti-Anxiety Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Anti-Anxiety Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Anti-Anxiety Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Anti-Anxiety Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Anti-Anxiety Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Anti-Anxiety Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Anti-Anxiety Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Anti-Anxiety Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-Anxiety Drugs Industry Trends
  2. 2.2 Anti-Anxiety Drugs Industry Drivers
  3. 2.3 Anti-Anxiety Drugs Industry Opportunities and Challenges
  4. 2.4 Anti-Anxiety Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-Anxiety Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-Anxiety Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-Anxiety Drugs Price (2021-2026)
  4. 3.4 Global Anti-Anxiety Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-Anxiety Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-Anxiety Drugs Company, Product Type & Application
  7. 3.7 Global Anti-Anxiety Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-Anxiety Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-Anxiety Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-Anxiety Drugs Tier 1, Tier 2, and Tier 3
4 Anti-Anxiety Drugs Regional Status and Outlook
  1. 4.1 Global Anti-Anxiety Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-Anxiety Drugs Historic Market Size by Region
  3. 4.2.1 Global Anti-Anxiety Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-Anxiety Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-Anxiety Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-Anxiety Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Anti-Anxiety Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-Anxiety Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-Anxiety Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-Anxiety Drugs by Application
  1. 5.1 Anti-Anxiety Drugs Market by Application
  2. 5.1.1 Help Sleep
  3. 5.1.2 Treat anxiety
  4. 5.1.3 Treat Premature Ejaculation
  5. 5.1.4 Others
  6. 5.2 Global Anti-Anxiety Drugs Market Size by Application
  7. 5.2.1 Global Anti-Anxiety Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Anti-Anxiety Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Anti-Anxiety Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Anti-Anxiety Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Anti-Anxiety Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Anti-Anxiety Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Anti-Anxiety Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Anti-Anxiety Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 JIANFENG Pharmaceutical
  2. 6.1.1 JIANFENG Pharmaceutical Company Information
  3. 6.1.2 JIANFENG Pharmaceutical Business Overview
  4. 6.1.3 JIANFENG Pharmaceutical Anti-Anxiety Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 JIANFENG Pharmaceutical Anti-Anxiety Drugs Product Portfolio
  6. 6.1.5 JIANFENG Pharmaceutical Recent Developments
  7. 6.2 HUAHAI PHARMACEUTICAL
  8. 6.2.1 HUAHAI PHARMACEUTICAL Company Information
  9. 6.2.2 HUAHAI PHARMACEUTICAL Business Overview
  10. 6.2.3 HUAHAI PHARMACEUTICAL Anti-Anxiety Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 HUAHAI PHARMACEUTICAL Anti-Anxiety Drugs Product Portfolio
  12. 6.2.5 HUAHAI PHARMACEUTICAL Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Anti-Anxiety Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Anti-Anxiety Drugs Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Gsk
  20. 6.4.1 Gsk Company Information
  21. 6.4.2 Gsk Business Overview
  22. 6.4.3 Gsk Anti-Anxiety Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Gsk Anti-Anxiety Drugs Product Portfolio
  24. 6.4.5 Gsk Recent Developments
  25. 6.5 KANGHONG PHARMACEUTICAL
  26. 6.5.1 KANGHONG PHARMACEUTICAL Company Information
  27. 6.5.2 KANGHONG PHARMACEUTICAL Business Overview
  28. 6.5.3 KANGHONG PHARMACEUTICAL Anti-Anxiety Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 KANGHONG PHARMACEUTICAL Anti-Anxiety Drugs Product Portfolio
  30. 6.5.5 KANGHONG PHARMACEUTICAL Recent Developments
  31. 6.6 Win Sunny
  32. 6.6.1 Win Sunny Company Information
  33. 6.6.2 Win Sunny Business Overview
  34. 6.6.3 Win Sunny Anti-Anxiety Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Win Sunny Anti-Anxiety Drugs Product Portfolio
  36. 6.6.5 Win Sunny Recent Developments
  37. 6.7 Zydus Pharmaceutical
  38. 6.7.1 Zydus Pharmaceutical Company Information
  39. 6.7.2 Zydus Pharmaceutical Business Overview
  40. 6.7.3 Zydus Pharmaceutical Anti-Anxiety Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Zydus Pharmaceutical Anti-Anxiety Drugs Product Portfolio
  42. 6.7.5 Zydus Pharmaceutical Recent Developments
  43. 6.8 Eli Lilly And Company
  44. 6.8.1 Eli Lilly And Company Company Information
  45. 6.8.2 Eli Lilly And Company Business Overview
  46. 6.8.3 Eli Lilly And Company Anti-Anxiety Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Eli Lilly And Company Anti-Anxiety Drugs Product Portfolio
  48. 6.8.5 Eli Lilly And Company Recent Developments
  49. 6.9 APOTEX
  50. 6.9.1 APOTEX Company Information
  51. 6.9.2 APOTEX Business Overview
  52. 6.9.3 APOTEX Anti-Anxiety Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 APOTEX Anti-Anxiety Drugs Product Portfolio
  54. 6.9.5 APOTEX Recent Developments
7 North America by Country
  1. 7.1 North America Anti-Anxiety Drugs Sales by Country
  2. 7.1.1 North America Anti-Anxiety Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-Anxiety Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-Anxiety Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-Anxiety Drugs Market Size by Country
  6. 7.2.1 North America Anti-Anxiety Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-Anxiety Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-Anxiety Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-Anxiety Drugs Sales by Country
  2. 8.1.1 Europe Anti-Anxiety Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-Anxiety Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-Anxiety Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-Anxiety Drugs Market Size by Country
  6. 8.2.1 Europe Anti-Anxiety Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-Anxiety Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-Anxiety Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-Anxiety Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Anti-Anxiety Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-Anxiety Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-Anxiety Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-Anxiety Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-Anxiety Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-Anxiety Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-Anxiety Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-Anxiety Drugs Sales by Country
  2. 10.1.1 South America Anti-Anxiety Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-Anxiety Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-Anxiety Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-Anxiety Drugs Market Size by Country
  6. 10.2.1 South America Anti-Anxiety Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-Anxiety Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-Anxiety Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-Anxiety Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Anti-Anxiety Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-Anxiety Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-Anxiety Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-Anxiety Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-Anxiety Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-Anxiety Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-Anxiety Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-Anxiety Drugs Value Chain Analysis
  2. 12.1.1 Anti-Anxiety Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-Anxiety Drugs Production Mode & Process
  7. 12.2 Anti-Anxiety Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-Anxiety Drugs Distributors
  10. 12.2.3 Anti-Anxiety Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst